Advertisement

Current Evidence

  • Thomas Muehlberger
Chapter

Abstract

The average success rate of migraine surgery, measured as either headache cessation or a substantial improvement, is higher than 80%. These results have been reproduced by multiple surgeons at multiple institutions. The quality of the evidence, however, does not match the unambiguity of the results. The majority of studies are retrospective, observational case series. There are several reasons for the current dearth of prospective, controlled trials in migraine surgery. Funding is a major obstacle. While manufactures of migraine medications are backing almost any trial on their products, they are an unlikely source of support of a surgical option. The multitude of co-variables among migraine patients are difficult to control in matched groups. The heterogeneity of surgical interventions is challenging the comparability of results. The only real equivalent of double-blind, randomized, controlled trials is sham surgery. Although perfectly feasible to evaluate the efficacy of procedures, sham surgery trials are very rarely granted approval by ethics commissions. Enthusiasts are generating better results than skeptics. The development of a standardized approach and the conduction of multicenter placebo surgery trials in alliance with neurologists would be a highly desirable future step for the benefit of migraine patients.

References

  1. 1.
    Glasziou P, Chalmers I, Rawlins M, McCulloch P. When are randomised trials unnecessary? Picking signal from noise. BMJ. 2007;334:349–51.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Blau JN. Migraine postdromes: symptoms after attacks. Cephalalgia. 1991;11:229–31.CrossRefPubMedGoogle Scholar
  3. 3.
    Guyuron B. Is migraine surgery ready for prime time? The surgical team’s view. Headache. 2015;55:1464–73.CrossRefPubMedGoogle Scholar
  4. 4.
    Guyuron B. A discussion of “critical evaluation of migraine trigger site decompression surgery”. Headache. 2014;54:1065–72.CrossRefPubMedGoogle Scholar
  5. 5.
    Mathew P. A critical re-evaluation of migraine trigger site decompression surgery. Headache. 2014;54:1231–3.CrossRefPubMedGoogle Scholar
  6. 6.
    Liu MT, Chim H, Guyuron B. Outcome comparison of endoscopic and transpalpebral decompression for treatment of frontal migraine headaches. Plast Reconstr Surg. 2012;129:1113–9.CrossRefPubMedGoogle Scholar
  7. 7.
    Kurlander DE, Ascha M, Sattar A, Guyuron B. In-depth review of symptoms, triggers, and surgical deactivation of frontal migraine headaches (site I). Plast Reconstr Surg. 2016;138:681–8.CrossRefPubMedGoogle Scholar
  8. 8.
    Kurlander DE, Punjabi A, Liu MT, Sattar A, Guyuron B. In-depth review of symptoms, triggers, and treatment of temporal migraine headaches (site II). Plast Reconstr Surg. 2014;133:897–903.CrossRefPubMedGoogle Scholar
  9. 9.
    Goldberg LD. The cost of migraine and its treatment. Am J Manag Care. 2005;11:S62–7.PubMedGoogle Scholar
  10. 10.
    Hawkins K, Wang S, Rupnow MF. Indirect cost burden of migraine in the United States. J Occup Environ Med. 2007;49:368–74.CrossRefPubMedGoogle Scholar
  11. 11.
    Faber C, Garcia RM, Davis J, Guyuron B. A socioeconomic analysis of surgical treatment of migraine headaches. Plast Reconstr Surg. 2012;129:871–7.CrossRefPubMedGoogle Scholar
  12. 12.
    Muehlberger T, Buschmann A, Toman N. The cost-effectiveness of the surgical treatment of migraine headaches. Plast Reconstr Surg. 2008;122(4S):160–1.Google Scholar
  13. 13.
    Guyuron B, Varghai A, Michelow BJ, Thomas T, Davis J. Corrugator supercilii muscle resection and migraine headaches. Plast Reconstr Surg. 2000;106:429–34.CrossRefPubMedGoogle Scholar
  14. 14.
    Guyuron B, Tucker T, Davis J. Surgical treatment of migraine headaches. Plast Reconstr Surg. 2002;109:2183–9.CrossRefPubMedGoogle Scholar
  15. 15.
    Guyuron B, Kriegler J, Davis J, Amini SB. Comprehensive surgical treatment of migraine headaches. Plast Reconstr Surg. 2005;115:1–9.PubMedGoogle Scholar
  16. 16.
    Guyuron B, Reed D, Kriegler JS, Davis J, Pashmini N, Amini S. A placebo-controlled surgical trial of the treatment of migraine headaches. Plast Reconstr Surg. 2009;124:461–8.CrossRefPubMedGoogle Scholar
  17. 17.
    Guyuron B, Kriegler JS, Davis J, Amini SB. Five-year outcome of surgical treatment of migraine headaches. Plast Reconstr Surg. 2011;127:603–8.CrossRefPubMedGoogle Scholar
  18. 18.
    Muehlberger T, Wormald JC, Hachach-Haram N, Mosahebi A. Migraine: a look down the nose. J Plast Reconstr Aesthet Surg. 2017;70:914–21.CrossRefPubMedGoogle Scholar
  19. 19.
    Ducic I, Felder JM, Fantus SA. A systematic review of peripheral nerve interventional treatments for chronic headaches. Ann Plast Surg. 2014;72:439–45.CrossRefPubMedGoogle Scholar
  20. 20.
    Gfrerer L, Guyuron B. Surgical treatment of migraine headaches. Acta Neurol Belg. 2016;117:27–32.CrossRefPubMedGoogle Scholar
  21. 21.
    Janis JE, Barker JC, Javadi C, Ducic I, Hagan R, Guyuron B. A review of current evidence in the surgical treatment of migraine headaches. Plast Reconstr Surg. 2014;134:S131–41.CrossRefGoogle Scholar
  22. 22.
    Kung TA, Guyuran B, Cederna PS. Migraine surgery: a plastic surgery solution for refractory migraine headache. Plast Recosntr Surg. 2011;127:181–9.CrossRefGoogle Scholar
  23. 23.
    Osborn TM. The surgical management of cephalalgia. Curr Opin Otolaryngol Head Neck Surg. 2016;24:359–67.CrossRefPubMedGoogle Scholar
  24. 24.
    Muehlberger T, Brittner W, Buschmann A, Toman N. Lasting outcome of the surgical treatment of migraine headaches – a four year follow-up. Plast Reconstr Surg. 2008;122(4S):32–3.Google Scholar
  25. 25.
    Molavi S, Zwiebel S, Gittleman H, Alleyne B, Guyuron B. The effect of preoperative migraine headache frequency on surgical outcomes. Plast Reconstr Surg. 2014;134:1306–11.CrossRefPubMedGoogle Scholar
  26. 26.
    Ansari H, Totonchi A. Surgical deactivation of trigger points in migraine: a case series and the importance of patient selection and surgical technique. Cephalalgia. 2015;35:44.Google Scholar
  27. 27.
    Bearden WH, Anderson RL. Corrugator superciliaris muscle excision for tension and migraine headaches. Ophthal Plast Reconstr Surg. 2005;21:418–22.CrossRefPubMedGoogle Scholar
  28. 28.
    Caruana G, Bertozzi N, Boschi E, et al. Endoscopic forehead surgery for migraine therapy. Personal technique. Ann Ital Chir. 2014;85:583–6.PubMedGoogle Scholar
  29. 29.
    de Ru JA, Schellekens PP, Lohuis PJ. Corrugator supercilii transection for headache emanating from the frontal region: a clinical evaluation of ten patients. J Neural Transm (Vienna). 2011;118:1571–4.CrossRefGoogle Scholar
  30. 30.
    Dirnberger F, Becker K. Surgical treatment of migraine headaches by corrugator muscle resection. Plast Reconstr Surg. 2004;114:652–7.CrossRefPubMedGoogle Scholar
  31. 31.
    Gfrerer L, Maman DY, Tessler O, et al. Nonendoscopic deactivation of nerve triggers in migraine headache patients: surgical technique and outcomes. Plast Reconstr Surg. 2014;134:771–8.CrossRefPubMedGoogle Scholar
  32. 32.
    Janis JE, Dhanik A, Howard JH. Validation of the peripheral trigger point theory of migraine headaches: single-surgeon experience using botulinum toxin and surgical decompression. Plast Reconstr Surg. 2011;128:123–31.CrossRefPubMedGoogle Scholar
  33. 33.
    Lin SH, Lin HC, Jeng CH, Hsieh CH, Lin YH, Chen CC. Experience of surgical treatment for occipital migraine in Taiwan. Ann Plast Surg. 2016;76:S80–4.CrossRefPubMedGoogle Scholar
  34. 34.
    Omranifard M, Abdali H, Ardakani MR, Talebianfar M. A comparison of outcome of medical and surgical treatment of migraine headache: in 1 year follow-up. Adv Biomed Res. 2016;5:121.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Poggi JT, Grizzell BE, Helmer SD. Confirmation of surgical decompression to relieve migraine headaches. Plast Reconstr Surg. 2008;122:115–22.CrossRefPubMedGoogle Scholar
  36. 36.
    Polotto S, Simonacci F, Grignaffini E, Grieco MP, Raposio E. Surgical treatment of frontal and occipital migraines: a comparison of results. Plast Reconstr Surg Glob Open. 2016;4:e653.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Matarasso A. Surgical treatment of migraine headaches. Arch Facial Plast Surg. 2002;4:274–5.CrossRefPubMedGoogle Scholar
  38. 38.
    Hougaard A, Tfelt-Hansen P. General lack of use of placebo in prophylactic, randomised, controlled trials in adult migraine. A systematic review. Cephalalgia. 2016;36:960–9.CrossRefPubMedGoogle Scholar
  39. 39.
    Campbell JN, Meyer RA. Mechanisms of neuropathic pain. Neuron. 2006;52:77–92.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Savulescu J, Wartolowska K, Carr A. Randomised placebo-controlled trials of surgery: ethical analysis and guidelines. J Med Ethics. 2016;42:776–83.CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Cobb LA, Thomas GI, Dillard DH, Merendino KA, Bruce RA. An evaluation of internal-mammary-artery ligation by a double-blind technic. N Engl J Med. 1959;260:1115–8.CrossRefPubMedGoogle Scholar
  42. 42.
    Wartolowska K, Judge A, Hopewell S, Collins GS, Dean BJ, Rombach I, Brindley D, Savulescu J, Beard DJ, Carr AJ. Use of placebo controls in the evaluation of surgery: systematic review. BMJ. 2014;348:g3253.CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Cooper JA, McNair L. Sham surgery research. J Empir Res Hum Res Ethics. 2015;10(5):496–8.CrossRefPubMedGoogle Scholar
  44. 44.
    Wartolowska K, Collins GS, Hopewell S, Judge A, Dean BJ, Rombach I, Beard DJ, Carr AJ. Feasibility of surgical randomised controlled trials with a placebo arm: a systematic review. BMJ Open. 2016;6:e010194.CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Punjabi A, Brown M, Guyuron B. Emergence of secondary trigger sites after primary migraine surgery. Plast Reconstr Surg. 2016;137:712e–6e.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Thomas Muehlberger
    • 1
  1. 1.Medsteps AGChamSwitzerland

Personalised recommendations